keyword
MENU ▼
Read by QxMD icon Read
search

Pneumococcal vaccines and journal vaccines

keyword
https://www.readbyqxmd.com/read/27765379/impact-of-pharmacists-as-immunizers-on-vaccination-rates-a-systematic-review-and-meta-analysis
#1
REVIEW
J E Isenor, N T Edwards, T A Alia, K L Slayter, D M MacDougall, S A McNeil, S K Bowles
BACKGROUND: Underutilization of vaccination programs remains a significant public health concern. Pharmacists serve as educators, facilitators, and in some jurisdictions, as administrators of vaccines. Though pharmacists have been involved with immunizations in various ways for many years, there has yet to be a systematic review assessing the impact of pharmacists as immunizers in these three roles. OBJECTIVE: To complete a systematic review of the literature on the impact of pharmacists as educators, facilitators, and administrators of vaccines on immunization rates...
November 11, 2016: Vaccine
https://www.readbyqxmd.com/read/27680425/evaluating-the-costs-and-benefits-of-pneumococcal-vaccination-in-adults
#2
Barbara Rita Porchia, Paolo Bonanni, Angela Bechini, Gugliemo Bonaccorsi, Sara Boccalini
Pneumococcal infection is a public health concern that disproportionately affects the young, the elderly, and the immunocompromised. There is an open debate on the implementation of polysaccharide and/or conjugate vaccines for pneumococcal diseases in adults and the elderly in many countries. The aim of this paper is to systematically review the economic profile of pneumococcal vaccines in adults in terms of costs and benefits. Areas covered: The search for economic studies on pneumococcal vaccination was carried out in Pubmed, Embase, Scopus, and the HTA and NHS EED databases and through a manual search in journals dealing with economic evaluations...
October 12, 2016: Expert Review of Vaccines
https://www.readbyqxmd.com/read/27313081/geriatrics-year-in-review
#3
REVIEW
Holly M Holmes, Maureen S Beck, Julie H Rowe
The purpose of this review is to provide an update on topics in general geriatrics that are of interest to the field of geriatric oncology. Based on a review of high-impact journals in geriatrics for the prior two years and reviews of journals in which geriatrics updates are published, updates for hypertension, dementia, vaccination, and frailty are presented here. Recent studies have supported lower, more aggressive blood pressure targets in the management of hypertension, even in older patients. However, controversy remains as to the cognitive and functional effects of aggressive blood pressure targets...
September 2016: Journal of Geriatric Oncology
https://www.readbyqxmd.com/read/27168324/correction-direct-comparison-of-immunogenicity-induced-by-10-or-13-valent-pneumococcal-conjugate-vaccine-around-the-11-month-booster-in-dutch-infants
#4
Alienke J Wijmenga-Monsuur, Els van Westen, Mirjam J Knol, Riet M C Jongerius, Marta Zancolli, David Goldblatt, Pieter G M van Gageldonk, Irina Tcherniaeva, Guy A M Berbers, Nynke Y Rots
[This corrects the article DOI: 10.1371/journal.pone.0144739.].
2016: PloS One
https://www.readbyqxmd.com/read/26651864/effects-of-staffing-and-regional-location-on-influenza-and-pneumococcal-vaccination-rates-in-nursing-home-residents
#5
Erin L Miller, Gregory L Alexander, Richard W Madsen
Vaccinations reduce the risk of hospitalizations and adverse health outcomes in older adult populations, which has led to initiatives such as the Healthy People 2010 goal to vaccinate 90% of all nursing home residents. The current analysis looked at the percentage of residents who received vaccinations in 15,653 nursing homes in the United States and relationships of vaccination to staffing intensity and regional location. Overall, approximately 75% of facilities reached the optimum 90% vaccination levels for long-term residents, but less than 50% reached this goal for short-term residents...
February 2016: Journal of Gerontological Nursing
https://www.readbyqxmd.com/read/26132952/vaccine-against-pneumococcal-pneumonia-in-adults
#6
LETTER
Marc J M Bonten, Susanne M Huijts, Marieke Bolkenbaas
New England Journal of Medicine, Volume 373, Issue 1, Page 91-93, July 2015.
July 2, 2015: New England Journal of Medicine
https://www.readbyqxmd.com/read/25676363/prior-pneumococcal-and-influenza-vaccinations-and-in-hospital-outcomes-for-community-acquired-pneumonia-in-elderly-veterans
#7
Chenghui Li, Paul O Gubbins, Guoqing J Chen
BACKGROUND: Studies of adults hospitalized for community-acquired pneumonia (CAP) reported better outcomes associated with prior pneumococcal vaccination (PV), suggesting potential additional benefits of PV in hospitalized CAP patients. Influenza (flu) vaccination (FV) could independently/additively improve CAP outcomes in hospitalized patients. OBJECTIVE: To examine the effect of prior PV and FV on in-hospital outcomes in elderly veterans hospitalized for CAP. DESIGN: Retrospective cohort study...
May 2015: Journal of Hospital Medicine: An Official Publication of the Society of Hospital Medicine
https://www.readbyqxmd.com/read/25596202/pneumococcal-conjugate-vaccines-prevenar13-and-synflorix-in-sequence-or-alone-in-high-risk-indigenous-infants-prev-ix_combo-protocol-of-a-randomised-controlled-trial
#8
RANDOMIZED CONTROLLED TRIAL
Amanda Jane Leach, Edward Kim Mulholland, Mathu Santosham, Paul John Torzillo, Ngiare Joy Brown, Peter McIntyre, Heidi Smith-Vaughan, Sue Skull, Anne Balloch, Ross Andrews, Jonathan Carapetis, Joseph McDonnell, Vicki Krause, Peter Stanley Morris
INTRODUCTION: Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living in remote areas of the Northern Territory (NT). OM and associated hearing loss persist from infancy throughout childhood and often into adulthood. Educational and social opportunities are greatly compromised. Pneumococcus and non-typeable Haemophilus influenzae (NTHi) are major OM pathogens that densely colonise the nasopharynx and infect the middle ear from very early in life. Our hypothesis is that compared to current single vaccine schedules, a combination of vaccines starting at 1 month of age, may provide earlier, broadened protection...
January 16, 2015: BMJ Open
https://www.readbyqxmd.com/read/25375222/prophylactic-antibiotics-for-preventing-pneumococcal-infection-in-children-with-sickle-cell-disease
#9
REVIEW
Ceri Hirst, Shirley Owusu-Ofori
Background This is an update of a Cochrane Review first published in 2002, and previously updated in 2012. People with sickle cell disease are particularly susceptible to infection. Infants and very young children are especially vulnerable, and the 'Co-operative Study of Sickle Cell Disease' observed an incidence rate of 10 per 100 patient years of pneumococcal septicaemia in children under the age of three.Vaccines, including customary pneumococcal vaccines, may be of limited use in this age group. Therefore, prophylactic penicillin regimens may be advisable for this population...
2014: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/25093421/pneumococcal-vaccines-for-cystic-fibrosis
#10
REVIEW
Laura Burgess, Kevin W Southern
BACKGROUND: Invasive pneumococcal disease is associated with significant mortality and many countries have introduced routine pneumococcal vaccination into their childhood immunisation programmes. Whilst pneumococcal disease in cystic fibrosis is uncommon, pneumococcal immunisation may offer some protection against pulmonary exacerbations caused by this pathogen. In the USA and UK pneumococcal vaccination is currently recommended for all children and adults with cystic fibrosis. OBJECTIVES: To assess the efficacy of pneumococcal vaccines in reducing morbidity in people with cystic fibrosis...
2014: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/24838102/non-publication-and-delayed-publication-of-randomized-trials-on-vaccines-survey
#11
Lamberto Manzoli, Maria Elena Flacco, Maddalena D'Addario, Lorenzo Capasso, Corrado De Vito, Carolina Marzuillo, Paolo Villari, John P A Ioannidis
OBJECTIVE: To evaluate the extent of non-publication or delayed publication of registered randomized trials on vaccines, and to investigate potential determinants of delay to publication. DESIGN: Survey. DATA SOURCES: Trials registry websites, Scopus, PubMed, Google. STUDY SELECTION: Randomized controlled trials evaluating the safety or the efficacy or immunogenicity of human papillomavirus (HPV), pandemic A/H1N1 2009 influenza, and meningococcal, pneumococcal, and rotavirus vaccines that were registered in ClinicalTrials...
2014: BMJ: British Medical Journal
https://www.readbyqxmd.com/read/24671198/correction-nasopharyngeal-carriage-and-transmission-of-streptococcus-pneumoniae-in-american-indian-households-after-a-decade-of-pneumococcal-conjugate-vaccine-use
#12
(no author information available yet)
[This corrects the article DOI: 10.1371/journal.pone.0079578.].
2014: PloS One
https://www.readbyqxmd.com/read/22972126/pneumococcal-vaccines-for-cystic-fibrosis
#13
REVIEW
Laura Burgess, Kevin W Southern
BACKGROUND: Invasive pneumococcal disease is associated with significant mortality and many countries have introduced routine pneumococcal vaccination into their childhood immunisation programmes. Whilst pneumococcal disease in cystic fibrosis is uncommon, pneumococcal immunisation may offer some protection against pulmonary exacerbations caused by this pathogen. In the USA and UK pneumococcal vaccination is currently recommended for all children and adults with cystic fibrosis. OBJECTIVES: To assess the efficacy of pneumococcal vaccines in reducing morbidity in people with cystic fibrosis...
2012: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/22972063/prophylactic-antibiotics-for-preventing-pneumococcal-infection-in-children-with-sickle-cell-disease
#14
REVIEW
Ceri Hirst, Shirley Owusu-Ofori
BACKGROUND: People with sickle cell disease are particularly susceptible to infection. Infants and very young children are especially vulnerable, and the 'Co-operative Study of Sickle Cell Disease' observed an incidence rate of 10 per 100 patient years of pneumococcal septicaemia in children under the age of three. Vaccines, including customary pneumococcal vaccines, may be of limited use in this age group. Therefore, prophylactic penicillin regimens may be advisable for this population...
2012: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/22935870/completeness-of-reporting-in-randomized-controlled-trials-of-3-vaccines-a-review-of-adherence-to-the-consort-checklist
#15
Pippa Scott, Franziska Ott, Matthias Egger, Nicola Low
BACKGROUND: Clear reporting of randomized controlled trials (RCTs) of vaccines is important for understanding results and assessing their validity. The CONsolidated Standards of Reporting Trials (CONSORT) statement provides guidance to help authors reporting RCTs. The objective was to assess the completeness of reporting of RCTs of vaccines based on the CONSORT 2010 checklist. METHODS: We collected data about items required by the CONSORT checklist or specific to trials of vaccines...
December 2012: Pediatric Infectious Disease Journal
https://www.readbyqxmd.com/read/20547899/acp-journal-club-pneumococcal-vaccine-reduced-pneumococcal-pneumonia-and-associated-mortality
#16
COMMENT
Thomas Fekete
No abstract text is available yet for this article.
June 15, 2010: Annals of Internal Medicine
https://www.readbyqxmd.com/read/19006533/community-acquired-pneumonia-cap-in-children-in-oslo-norway
#17
Anita C Senstad, Pål Surén, Lin Brauteset, Jan R Eriksson, Ernst Arne Høiby, Karl-Olaf Wathne
AIM: To investigate the epidemiology and clinical characteristics of community acquired pneumonia (CAP) in children before the introduction of the 7-valent pneumococcal vaccine in the national vaccination programme. METHODS: For the period 21 May 2003 to 20 May 2005 hospitalization rates for pneumonia in children were obtained from retrospective studies of medical journals. Pneumonia was also studied prospectively in children less than sixteen years old referred to Ullevål University Hospital (Oslo) in the same time period...
February 2009: Acta Paediatrica
https://www.readbyqxmd.com/read/18418479/pneumococcal-conjugate-vaccination-in-canadian-infants-and-children-younger-than-five-years-of-age-recommendations-and-expected-benefits
#18
Carol A McClure, Michael W Ford, Jeff B Wilson, Jeff J Aramini
INTRODUCTION: Streptococcus pneumoniae infection may result in invasive pneumococcal disease (IPD), such as bacteremia, meningitis and bacteremic pneumonia, or in non-IPD, such as pneumonia, sinusitis and otitis media. In June 2001, a heptavalent pneumococcal conjugate vaccine (PCV7) (Prevnar, Wyeth Pharmaceuticals, Canada) was approved for use in children in Canada. The objective of the present paper is to review S pneumoniae-induced disease incidence and vaccine recommendations in Canadian infants and children younger than five years of age...
January 2006: Canadian Journal of Infectious Diseases & Medical Microbiology
https://www.readbyqxmd.com/read/14974042/pneumococcal-vaccines-for-sickle-cell-disease
#19
REVIEW
E G Davies, C Riddington, R Lottenberg, N Dower
BACKGROUND: People with sickle cell disease are particularly susceptible to pneumococcal infection, which may be fatal. Infants (children aged up to 23 months) are at particularly high risk, but conventional polysaccharide pneumococcal vaccines may be ineffective in this age group. New conjugate pneumococcal vaccines are now available, which may help to reduce the incidence of infection in people with sickle cell disease. OBJECTIVES: To determine the efficacy of pneumococcal vaccines for reducing morbidity and mortality in people with sickle cell disease...
2004: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/12137693/prophylactic-antibiotics-for-preventing-pneumococcal-infection-in-children-with-sickle-cell-disease
#20
REVIEW
C Riddington, S Owusu-Ofori
BACKGROUND: People with sickle cell disease are particularly susceptible to infection. Infants and very young children are especially vulnerable, and the Cooperative Study of Sickle Cell Disease observed an incidence rate of 10 per 100 patient years of pneumococcal septicaemia in children under the age of three. Vaccines, including customary pneumococcal vaccines, may be of limited use in this age group. Therefore, prophylactic penicillin regimes may be advisable for this population. OBJECTIVES: To assess the effects of prophylactic antibiotic regimes for preventing pneumococcal infection in children with sickle cell disease...
2002: Cochrane Database of Systematic Reviews
keyword
keyword
4958
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"